Hamdard Labs starts clinical trials of two drugs to evaluate efficacy to prevent COVID-19 infection Read more
Researchers develop compound to kill gram-positive and gram-negative antibiotic-resistant superbugs Read more
INmune Bio gets US FDA nod for Phase II trial of Quellor, a sTNF inhibitor for COVID-19 treatment Read more
Empagliflozin reduced risk of death and hospitalisation for heart failure by 25 per cent in adults Read more